Navigation Links
Beckman Coulter Announces First in Series of Flow Cytometry Product Introductions for 2009
Date:3/12/2009

Gallios(TM) Flow Cytometry System Offers New Standard of Performance for Researchers

ORANGE COUNTY, Calif., March 12 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC), a leading developer, and manufacturer of products that simplify and automate complex biomedical testing, announced today that it has launched the Gallios Flow Cytometer, the first of several instrument, software and reagent introductions in the year for both clinical and research applications in flow cytometry.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO)

The new Gallios Flow Cytometer, targeted to the research market, delivers analytical excellence combined with high speed data collection. Features - including advanced optics, patented electronics design, and novel software tools - improve lab workflow and quality control, delivering increased sensitivity and resolution in less time and at higher speeds. Researchers can readily see small and subtle changes in cell populations, and the system accelerates data generation.

"Every aspect of the Gallios design increases application performance. When combined with our broad and high quality reagent portfolio, we provide a new and powerful solution for cellular analysis, increasing productivity and improving the reliability and reproducibility of results," said Cynthia Collins, group vice president of Cellular Analysis at Beckman Coulter.

The analyzer's efficient, compact design allows laboratories to maximize valuable space. The system comes in three scaleable configurations that allow for future addition of more lasers and fluorescence detectors as the need for complex multi-color flow cytometry expands.

Collins added, "We are adding a number of exciting products to our flow cytometry portfolio this year. They are a testament to our commitment to enhancing the efficiency of flow cytometry laboratories around the globe."

About Beckman Coulter

Beckman Coulter, Inc., based in Orange County, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of supplies, test kits and operating-type lease payments, represents approximately 78 percent of the company's 2008 annual revenue of $3.1 billion. For more information, visit www.beckmancoulter.com.

    Contacts:  Mary Luthy, Beckman Coulter   Cynthia Skoglund, Beckman Coulter
               Corporate Communications      Investor Relations
               (714) 773-7964                (714) 773-7620


'/>"/>
SOURCE Beckman Coulter, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Beckman Coulter to Present at Upcoming Healthcare Conferences
2. Beckman Coulter Announces Third Quarter 2008 Results
3. Beckman Coulter to Present at the Morgan Stanley Global Healthcare Unplugged Conference
4. Beckman Coulter Announces First Quarter 2008 Earnings to be Released on Wednesday, April 30, 2008, Before Market Opens
5. Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10.8% and 9.2%, Respectively; 2007 Earnings Per Share Beat Outlook
6. Beckman Coulter to Present at the 2007 RBC Capital Markets Healthcare Conference
7. Beckman Coulter to Acquire Flow Cytometry Instrumentation Business From Dako
8. Beckman Coulter to Present at the Credit Suisse Global Healthcare Conference
9. Beckman Coulter Signs Agreements With Amerinet, Inc.; Ten-Year Partnership Extended for Another Three Years
10. Beckman Coulter Announces Licensing Option Agreements for Cancer Genes with Johns Hopkins University
11. Meditor Pharmaceuticals (North American) Ltd. announces the closing of a merger agreement with American Medical Technologies, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... ... ... Axiad IDS , a leading provider of trusted identities for enterprise, ... a “Top 25 Cybersecurity Companies 2017.” Axiad IDS received this honor in ... address potential cybersecurity threats before they happen. The annual list of top ...
(Date:5/23/2017)... (PRWEB) , ... May 23, 2017 , ... ... the pharmaceutical and medical device sectors, today announced the winners of its 3rd ... Entrepreneurs) represent the most influential people in the healthcare industry today. , Out ...
(Date:5/23/2017)... ... May 23, 2017 , ... New England Journal Of Medicine Confirms Viability of ... Response”, -The Rory Staunton Foundation Calls on Health & Human Services, Tom Price to ... ( http://www.rorystauntonfoundation.org ) today reported on a new study released on May 21, 2017 ...
(Date:5/23/2017)... ... May 23, 2017 , ... The National ... is pleased to announce the organization’s Certified Strength Coach credential has earned accreditation ... Coach (CSC) program validates the competency of qualified candidates for jobs in the ...
(Date:5/23/2017)... ... May 23, 2017 , ... ... Reconstructive Surgeon Dr. Kevin Sadati, is pleased to announce a new treatment option ... and elastin in their face, neck, and body through a virtually pain-free, non-surgical ...
Breaking Medicine News(10 mins):
(Date:5/4/2017)... Fix Inc. (" Fortuna "), a private, clinical-stage biotech ... need for embryonic and fetal stem cells by using direct ... Fortuna announced today the launch of its Scientific ... PhD; Father Kevin FitzGerald , S.J., PhD; Col. (R) ... Giordano , PhD. "We are excited and honored ...
(Date:5/4/2017)... , May 4, 2017  DarioHealth Corp. (NASDAQ: ... health and big data solutions, today announced that it ... Company, and STI Technologies Limited to lower diabetes healthcare ... Through STI,s innoviCares card, which is available throughout all ... DarioHealth customers will be eligible for additional savings when ...
(Date:5/3/2017)... ROCKVILLE, Md. , May 3, 2017 /PRNewswire/ ... revenue growth of nine percent next year and ... solid organ and hematopoietic stem cell (HSCT) or ... and donor. Molecular testing technologies are well-suited for this ... healthcare-only market research publisher Kalorama Information. The various ...
Breaking Medicine Technology: